Core Viewpoint - The company, Innovation Medical Management Co., Ltd., reported a slight decrease in revenue but a significant improvement in net profit compared to the previous year, indicating a potential recovery in financial performance [1]. Financial Performance - Revenue for the reporting period was approximately ¥401.53 million, a decrease of 1.60% compared to ¥408.04 million in the same period last year [1]. - The net profit attributable to shareholders was a loss of ¥11.36 million, which is an improvement of 29.12% from a loss of ¥16.03 million in the previous year [1]. - The net profit after deducting non-recurring gains and losses was a loss of ¥12.88 million, showing a 22.42% improvement from a loss of ¥16.61 million last year [1]. - The net cash flow from operating activities was ¥83.72 million, a significant increase of 2,578.88% compared to a negative cash flow of ¥3.38 million in the previous year [1]. - Basic and diluted earnings per share improved to -¥0.03 from -¥0.04, reflecting a 25.00% increase [1]. Asset and Equity Position - Total assets at the end of the reporting period were approximately ¥2.15 billion, a decrease of 2.25% from ¥2.20 billion at the end of the previous year [1]. - The net assets attributable to shareholders were approximately ¥1.76 billion [1]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 82,043 [2]. - The largest shareholder, Chen Xiaying, holds 17.59% of the shares, while other significant shareholders include Chen Haijun with 5.04% and Shanghai Guanghuan Technology Co., Ltd. with 4.97% [2]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [2].
创新医疗: 2025年半年度报告摘要